Table 3.

Outcomes of the 12 patients with AS-AIH treated with corticosteroids

Patients	Days before treatment (days)	Changes (Δ) of Day-3 postcorticosteroid treatment			Alive (Y/N)	Relapse (Y/N)	Follow-up period (months)
		Δ ALT (IU/L)	Δ TBIL (μmol/L)	Δ INR
1	20	−65	−41	−0.08	Y	N	75
2	7	−102	−10.1	−0.25	Y	N	117
3	10	−47	−45	−0.13	Y	N	108
4	15	−21	−12.8	−0.01	Y	N	25
5	30	−201	−37	+ 0.02	Y	N	61
6	20	−146	−60.4	−0.29	Y	N	29
7	40	−15	−2.5	−0.5	Y	N	44
8	10	−382	−40.3	−0.34	Y	N	24
9	8	−78	−2.3	+ 0.03	Y	N	66
10	30	−34	−21.6	+ 0.02	Y	Y	28
11	60	−12	+ 32	+ 0.25	N
12	70	+ 37	+ 66.9	+ 0.01	N

Δ, change; Y, yes; N, no; −, decrease; + , increase

Days before treatment: intervals between onset of symptoms and initiation of corticosteroid therapy